BlackRock, Inc. 13D and 13G filings for Capricor Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-05 5:28 pm Purchase | 2024-12-31 | 13G | Capricor Therapeutics, Inc. CAPR | BlackRock Inc. BLK | 2,966,914 6.500% | 1,216,907 (+69.54%) | Filing |
| 2024-11-12 11:46 am Unchanged | 2024-09-30 | 13G | Capricor Therapeutics, Inc. CAPR | BlackRock Inc. BLK | 1,750,007 5.400% | 0 (Unchanged) | Filing |
| 2024-10-24 2:02 pm Purchase | 2024-09-30 | 13G | Capricor Therapeutics, Inc. CAPR | BlackRock Inc. BLK | 1,750,007 5.400% | 1,750,007 (New Position) | Filing |